Pharming Group N.V. announced that Robert Friesen, Chief Scientific Officer and Executive Board member resigned from his role. Mr. Friesen's succession is currently under review.
Market Closed -
Other stock markets
|
After market 20:34:09 | |||
0.814 EUR | -0.79% | 0.813 | -0.12% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.05% | 599M | |
+42.77% | 739B | |
+32.34% | 598B | |
-5.55% | 353B | |
+17.75% | 318B | |
+3.77% | 285B | |
+16.47% | 240B | |
+9.26% | 210B | |
-5.07% | 206B | |
+6.67% | 164B |
- Stock Market
- Equities
- PHARM Stock
- News Pharming Group N.V.
- Pharming Group N.V. Announces Resignation of Robert Friesen, Chief Scientific Officer and Executive Board Member